A total of 207 students, faculty, and staff consented to participate in the study. Thirty-four participants did not complete the surveys and were removed from the analyses. The final sample included 173 participants
(56 students and 117 faculty/staff) with complete data (
Table 1). The mean (SD) age of participants was 35.1 (16.7) years, 108 (62.4%) identified as female, 142 (82.1%) were white, and 74 (42.8%) had a 4-year degree or higher (
Table 1). Of the 173 participants, 85 (49.1%) self-reported a diagnosis of T1DM and 88 (50.9%) self-reported a diagnosis of T2DM. Overall, the participants had an average HbA
1C of 7.3% (1.4%) and a diabetes duration of 10.5 (9.5) years. The average body mass index (BMI) was 30.0 (7.6) kg/m
2, 43.4% reported taking insulin, and 98.3% had insurance coverage. Participants with T1DM were younger (24.5 [9.3] vs 45.4 (15.8) years,
t =−10.567,
P<.001), had a longer diabetes duration (12.8 [8.8] vs 8.2 [9.6] years,
t=3.203,
P=.002), a higher HbA
1C (7.8% [1.6%] vs 6.8% (1.0%);
t=5.022,
P<.001), and a lower BMI (26.6 [6.6] kg/m
2 vs 33.2 (7.0) kg/m
2;
t=−6.293,
P<.001) compared with the participants with T2DM. Also, participants with T1DM differed by type of diabetes medication (χ
2=127.780,
df=4,
P<.001) and level of education (χ
2=58.149,
df=8,
P<.001) compared with participants with T2DM. No differences were observed by gender, race, ethnicity, or insurance coverage. No gender differences in high diabetes distress scores (χ
2=0.023,
df=1,
P=.880) or severe depression (
P=.514) were observed.